These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34696978)

  • 1. Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.
    Yoo A; Fennelly JE; Renauer MM; Coe AB; Choe HM; Marshall VD; Parsons D; Farris KB
    J Am Pharm Assoc (2003); 2022; 62(2):580-587.e1. PubMed ID: 34696978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
    O'Shea TE; Zarowitz BJ; Erwin WG
    J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
    Miller DE; Roane TE; Salo JA; Hardin HC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
    Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key informant perspectives about telephonic comprehensive medication review services in the United States.
    Anderson EJ; Dhatt H; Vaffis S; Nelson ML; Warholak T; Campbell PJ; Black H; Kolobova I; Axon DR
    J Am Pharm Assoc (2003); 2022; 62(3):817-825.e1. PubMed ID: 35067476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
    Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A checklist for a consistent, comprehensive medication review.
    Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
    J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative analysis of telephonic comprehensive medication review content and delivery.
    Dhatt H; Vaffis S; Le D; Axon DR; Campbell PJ; Black H; Kolobova I; Nelson ML; Warholak T
    J Am Pharm Assoc (2003); 2023; 63(2):555-565. PubMed ID: 36481091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
    Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
    J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Medication Review Completion in Medically Underserved Areas and Populations.
    Le LD; Paulk IR; Axon DR; Bingham JM
    J Health Care Poor Underserved; 2021; 32(3):1301-1311. PubMed ID: 34421032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare medication therapy Management: Beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013 to 2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024; 64(5):102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
    Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
    Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
    Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
    J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.
    Coe AB; Choe HM; Diez HL; Rockey NG; Ashjian EJ; Dorsch MP; Kim HM; Farris KB
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1558-1566. PubMed ID: 33251995
    [No Abstract]   [Full Text] [Related]  

  • 18. Web-Based Electronic Health Record Program: A Twelve-Month Evaluation on Pharmacist's Intervention in Medicare Part D Annual Comprehensive Medication Review.
    Chong MT; Chong DS
    J Pharm Pract; 2024 Feb; 37(1):132-139. PubMed ID: 36122167
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
    Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
    Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.